Significant progress in trials of HIV vaccine in France

France's National AIDS Institute announced on the 22nd, the latest completed long-term trial confirmed that the synthetic AIDS vaccine not only has a higher immune effect, but also can be injected by intracutaneous injection instead of intramuscular injectionThe results were published in the same day in the Journal of the Public Library of ScienceCristina Simon, an expert at France's National AIDS Institute, told Xinhua in an interview that the trial has tested the feasibility of vaccination against AIDS through intratheal injection, which will significantly reduce the cost of vaccination and will help make it universal in developing countriesShe explained that intracutaneous injections require a much smaller dose than intramuscular injectionsUp to now, however, most vaccinations have been done with intramuscular injections, with the exception of cacaoAs far as she knows, laboratories in a number of countries are currently conducting intra-in-skin research on viral influenza vaccines in response to pandemic influenza, but the French trial is the first in the field of research into the inderite of the AIDS vaccineShe said that the main component of the synthetic AIDS trial vaccine is a mixture of several lipid peptidesThe latest trial, which began in 2004, divided 68 volunteers from healthyhealth
groups into two groups, one receiving traditional intramuscular injections and the other receiving intracutaneous injections, but at a dose of only one-fifth of the intramuscular injection groupThe results showed that the experimental vaccine did not have any serious toxic side effects on the human body, and the tolerance of the inderite group to the vaccine was satisfactoryAt the same time, 52 percent of the volunteers in the intraderological injection group and 37 percent of the intramuscular injection group received an anti-HIV immune responseShe said the trials showed that the experimental vaccine had a higher immune effect and could be fully inoculated by inthevesinationHowever, the expert also said that although their research has made significant progress, but the AIDS vaccine is still in the experimental stage, formally put into clinical use will take some time